Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation

Published:2019-09 Issue:3 Volume:156 Page:529-543
ISSN:0012-3692
Container-title:Chest
language:en
Short-container-title:Chest

Author:

Chan Yi-Hsin,Lee Hsin-Fu,See Lai-Chu,Tu Hui-Tzu,Chao Tze-Fan,Yeh Yung-Hsin,Wu Lung-Sheng,Kuo Chi-Tai,Chang Shang-Hung,Lip Gregory Y.H.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine

Reference32 articles.

1. Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making;Lip;Thromb Haemost,2017

2. Dabigatran versus warfarin in patients with atrial fibrillation;Connolly;N Engl J Med,2009

3. Rivaroxaban versus warfarin in nonvalvular atrial fibrillation;Patel;N Engl J Med,2011

4. Apixaban versus warfarin in patients with atrial fibrillation;Granger;N Engl J Med,2011

5. Edoxaban versus warfarin in patients with atrial fibrillation;Giugliano;N Engl J Med,2013

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and Safety of Early Versus Routine Switching from Low-Molecular-Weight Heparin to Maintenance Therapy of Rivaroxaban for Acute Iliofemoral Vein Thrombosis: A Retrospective Cohort Study;Annals of Vascular Surgery;2024-09

2. Comparative Effectiveness and Safety of Off-Label Underdosed Direct Oral Anticoagulants in Asian Patients with Atrial Fibrillation: A Systematic Review and Meta-analysis;Drug Safety;2024-08-30

3. Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in low-weight patients with atrial fibrillation;Journal of Thrombosis and Thrombolysis;2024-08-14

4. Effects of the antitumor drugs adagrasib and asciminib on apixaban metabolism in vitro and in vivo;Chemico-Biological Interactions;2024-08

5. Idarucizumab in dabigatran-treated patients with acute stroke: a review and clinical update;Frontiers in Neurology;2024-05-16

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3